Difficulty: Medium
Average Score: 88%
Practice
Which patient is the best candidate to receive nesiritide therapy?
Correct answer
D
Rationale
Nesiritide is a recombinant form of human B-type natriuretic peptide (BNP) that is used for the treatment of acutely decompensated heart failure (HF). It is specifically indicated for patients with acute decompensated HF who have dyspnea at rest. Nesiritide works by promoting vasodilation and natriuresis, which helps alleviate symptoms of acute decompensated HF such as dyspnea and edema. Therefore, the patient with acutely decompensated HF who has dyspnea at rest is the best candidate to receive nesiritide therapy to help improve their symptoms and hemodynamic status.